203 related articles for article (PubMed ID: 37373505)
1. Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination.
Kleinfelder K; Villella VR; Hristodor AM; Laudanna C; Castaldo G; Amato F; Melotti P; Sorio C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373505
[TBL] [Abstract][Full Text] [Related]
2. CFTR Modulators Rescue the Activity of CFTR in Colonoids Expressing the Complex Allele p.[R74W;V201M;D1270N]/dele22_24.
Kleinfelder K; Somenza E; Farinazzo A; Conti J; Lotti V; Latorre RV; Rodella L; Massella A; Tomba F; Bertini M; Sorio C; Melotti P
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982273
[TBL] [Abstract][Full Text] [Related]
3. CFTR Function Restoration upon Elexacaftor/Tezacaftor/Ivacaftor Treatment in Patient-Derived Intestinal Organoids with Rare
Lefferts JW; Bierlaagh MC; Kroes S; Nieuwenhuijze NDA; Sonneveld van Kooten HN; Niemöller PJ; Verburg TF; Janssens HM; Muilwijk D; van Beuningen SFB; van der Ent CK; Beekman JM
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833986
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Assessment of
Efremova A; Kashirskaya N; Krasovskiy S; Melyanovskaya Y; Krasnova M; Mokrousova D; Bulatenko N; Kondratyeva E; Makhnach O; Bukharova T; Zinchenko R; Kutsev S; Goldshtein D
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474016
[TBL] [Abstract][Full Text] [Related]
5. Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination.
Veit G; Roldan A; Hancock MA; Da Fonte DF; Xu H; Hussein M; Frenkiel S; Matouk E; Velkov T; Lukacs GL
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32853178
[TBL] [Abstract][Full Text] [Related]
6. Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis.
Dekkers JF; Berkers G; Kruisselbrink E; Vonk A; de Jonge HR; Janssens HM; Bronsveld I; van de Graaf EA; Nieuwenhuis EE; Houwen RH; Vleggaar FP; Escher JC; de Rijke YB; Majoor CJ; Heijerman HG; de Winter-de Groot KM; Clevers H; van der Ent CK; Beekman JM
Sci Transl Med; 2016 Jun; 8(344):344ra84. PubMed ID: 27334259
[TBL] [Abstract][Full Text] [Related]
7. Extent of rescue of F508del-CFTR function by VX-809 and VX-770 in human nasal epithelial cells correlates with SNP rs7512462 in SLC26A9 gene in F508del/F508del Cystic Fibrosis patients.
Kmit A; Marson FAL; Pereira SV; Vinagre AM; Leite GS; Servidoni MF; Ribeiro JD; Ribeiro AF; Bertuzzo CS; Amaral MD
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1323-1331. PubMed ID: 30716472
[TBL] [Abstract][Full Text] [Related]
8. Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription.
Dreano E; Burgel PR; Hatton A; Bouazza N; Chevalier B; Macey J; Leroy S; Durieu I; Weiss L; Grenet D; Stremler N; Ohlmann C; Reix P; Porzio M; Roux Claude P; Rémus N; Douvry B; Montcouquiol S; Cosson L; Mankikian J; Languepin J; Houdouin V; Le Clainche L; Guillaumot A; Pouradier D; Tissot A; Priou P; Mély L; Chedevergne F; Lebourgeois M; Lebihan J; Martin C; Zavala F; Da Silva J; Lemonnier L; Kelly-Aubert M; Golec A; Foucaud P; Marguet C; Edelman A; Hinzpeter A; de Carli P; Girodon E; Sermet-Gaudelus I; Pranke I;
Eur Respir J; 2023 Oct; 62(4):. PubMed ID: 37696564
[TBL] [Abstract][Full Text] [Related]
9. Potentiator synergy in rectal organoids carrying S1251N, G551D, or F508del CFTR mutations.
Dekkers JF; Van Mourik P; Vonk AM; Kruisselbrink E; Berkers G; de Winter-de Groot KM; Janssens HM; Bronsveld I; van der Ent CK; de Jonge HR; Beekman JM
J Cyst Fibros; 2016 Sep; 15(5):568-78. PubMed ID: 27160424
[TBL] [Abstract][Full Text] [Related]
10. L1077P CFTR pathogenic variant function rescue by Elexacaftor-Tezacaftor-Ivacaftor in cystic fibrosis patient-derived air-liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients.
Lo Cicero S; Castelli G; Blaconà G; Bruno SM; Sette G; Pigliucci R; Villella VR; Esposito S; Zollo I; Spadaro F; Maria R; Biffoni M; Cimino G; Amato F; Lucarelli M; Eramo A
Respir Res; 2023 Sep; 24(1):217. PubMed ID: 37674160
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Complex p.[Leu467Phe;Phe508del] CFTR Allele in the Intestinal Organoids Model: Implications for Therapy.
Kondratyeva E; Efremova A; Melyanovskaya Y; Voronkova A; Polyakov A; Bulatenko N; Adyan T; Sherman V; Kovalskaia V; Petrova N; Starinova M; Bukharova T; Kutsev S; Goldshtein D
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142302
[TBL] [Abstract][Full Text] [Related]
12. Molecular Dynamics and Theratyping in Airway and Gut Organoids Reveal R352Q-CFTR Conductance Defect.
Wong SL; Awatade NT; Astore MA; Allan KM; Carnell MJ; Slapetova I; Chen PC; Setiadi J; Pandzic E; Fawcett LK; Widger JR; Whan RM; Griffith R; Ooi CY; Kuyucak S; Jaffe A; Waters SA
Am J Respir Cell Mol Biol; 2022 Jul; 67(1):99-111. PubMed ID: 35471184
[TBL] [Abstract][Full Text] [Related]
13. Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast.
Latorre RV; Calicchia M; Bigliardi M; Conti J; Kleinfelder K; Melotti P; Sorio C
Respir Investig; 2024 May; 62(3):455-461. PubMed ID: 38547757
[TBL] [Abstract][Full Text] [Related]
14. Functional Restoration of CFTR Nonsense Mutations in Intestinal Organoids.
de Poel E; Spelier S; Suen SWF; Kruisselbrink E; Graeber SY; Mall MA; Weersink EJM; van der Eerden MM; Koppelman GH; van der Ent CK; Beekman JM
J Cyst Fibros; 2022 Mar; 21(2):246-253. PubMed ID: 34666947
[TBL] [Abstract][Full Text] [Related]
15. FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes.
de Poel E; Spelier S; Hagemeijer MC; van Mourik P; Suen SWF; Vonk AM; Brunsveld JE; Ithakisiou GN; Kruisselbrink E; Oppelaar H; Berkers G; de Winter de Groot KM; Heida-Michel S; Jans SR; van Panhuis H; Bakker M; van der Meer R; Roukema J; Dompeling E; Weersink EJM; Koppelman GH; Blaazer AR; Muijlwijk-Koezen JE; van der Ent CK; Beekman JM
J Cyst Fibros; 2023 May; 22(3):548-559. PubMed ID: 37147251
[TBL] [Abstract][Full Text] [Related]
16. Forskolin induced swelling (FIS) assay in intestinal organoids to guide eligibility for compassionate use treatment in a CF patient with a rare genotype.
Aalbers BL; Brunsveld JE; van der Ent CK; van den Eijnden JC; Beekman JM; Heijerman HGM
J Cyst Fibros; 2022 Mar; 21(2):254-257. PubMed ID: 35110005
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the mechanism of action of RDR01752, a novel corrector of F508del-CFTR.
Lopes-Pacheco M; Silva IAL; Turner MJ; Carlile GW; Sondo E; Thomas DY; Pedemonte N; Hanrahan JW; Amaral MD
Biochem Pharmacol; 2020 Oct; 180():114133. PubMed ID: 32628927
[TBL] [Abstract][Full Text] [Related]
18. Organoids as a personalized medicine tool for ultra-rare mutations in cystic fibrosis: The case of S955P and 1717-2A>G.
Silva IAL; Doušová T; Ramalho S; Centeio R; Clarke LA; Railean V; Botelho HM; Holubová A; Valášková I; Yeh JT; Hwang TC; Farinha CM; Kunzelmann K; Amaral MD
Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165905. PubMed ID: 32730979
[TBL] [Abstract][Full Text] [Related]
19. VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.
Davies JC; Moskowitz SM; Brown C; Horsley A; Mall MA; McKone EF; Plant BJ; Prais D; Ramsey BW; Taylor-Cousar JL; Tullis E; Uluer A; McKee CM; Robertson S; Shilling RA; Simard C; Van Goor F; Waltz D; Xuan F; Young T; Rowe SM;
N Engl J Med; 2018 Oct; 379(17):1599-1611. PubMed ID: 30334693
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.
Heijerman HGM; McKone EF; Downey DG; Van Braeckel E; Rowe SM; Tullis E; Mall MA; Welter JJ; Ramsey BW; McKee CM; Marigowda G; Moskowitz SM; Waltz D; Sosnay PR; Simard C; Ahluwalia N; Xuan F; Zhang Y; Taylor-Cousar JL; McCoy KS;
Lancet; 2019 Nov; 394(10212):1940-1948. PubMed ID: 31679946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
